Navigation Links
Nile Therapeutics Reports 2010 Third Quarter Financial Results
Date:11/12/2010

SAN MATEO, Calif., Nov. 12, 2010 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a company focused on the development of novel therapeutics for therapeutics for cardiovascular disease, today announced its third quarter financial results for 2010.

Financial ResultsFor the three months ended September 30, 2010, Nile reported a net loss of approximately $1.8 million, or $0.05 per share, compared to a net loss of approximately $2.0 million, or $0.08 per share, during the third quarter of 2009. Weighted-average shares outstanding for the third quarter were 34.6 million.

Net cash used in operating activities in the third quarter of 2010 was approximately $1.1 million. As of September 30, 2010, Nile had cash and cash equivalents of approximately $4.4 million compared to approximately $3.2 million as of December 31, 2009.

Qualifying Therapeutic Discovery Project GrantNile was recently awarded a $244,479 grant under the Internal Revenue Service's Qualifying Therapeutic Discovery Project program, which was established under the U.S. Patient Protection and Affordable Care Act of 2010.  The Company expects to receive the grant funds prior to the end of 2010.

Update on CD-NPOn November 2, Nile announced that CD-NP met the primary end-point, safety and tolerability, in an open-label, single-blind, placebo-controlled Phase 2 study of 77 patients with acute decompensated heart failure (ADHF) and renal dysfunction. Additionally, secondary analyses demonstrated favorable effects of CD-NP on renal function.

An infusion of CD-NP for up to 72 hours at doses of 1.25 and 2.5 ng/kg/min appeared to be well tolerated.  A dose-dependent effect on blood pressure was observed, with minimal or mild blood pressure reduction at 1.25 and 2.5 ng/kg/min, and moderate blood pressure reduction at 3.75 ng/kg/min.  Dose escalation was limited by
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... June 17, 2013  As the Share Repurchase Resolution has ... Offer for Elan Corporation, plc (NYSE: ELN ) ... outcome of the Proceedings referred to below and any consequent ... to be effective to the extent that it would have ... of the Share Repurchase Resolution being passed. There can be ...
(Date:6/17/2013)... PARSIPPANY, N.J. , June 17, 2013 Actavis, ... United States Supreme Court has reversed the decision of the ... affirmed the District Court,s ruling granting Actavis, motion to dismiss ... .  The Supreme Court,s reversal was the result of a ... the FTC,s proposed "quick look" approach and adopted the traditional ...
(Date:6/17/2013)... , June 17, 2013 The Biozoom ... portable, hand held device for the non-invasive transdermal ... human body. It replaces expensive, time consuming and ... a button, the Biozoom scanner reflects a beam ... Zeiss—and measures the reflection. Using the scanner, researchers ...
Breaking Medicine Technology:Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 2Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 3Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 4Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 5Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 6Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 7Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 8Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 9Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today 10U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 2U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 3University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 2University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 3University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 4
... Sheffield Bio-Science, a leading global pharmaceutical supplier of superior ... markets, has been awarded the distinguished 2010 Lilly Global Supplier Award. ... The ... and services for Eli Lilly and Company over the years and ...
... ATLANTA , July 12 Holon, the new ... Medication Management solution. , ... Leveraging the Holon Process Adaptive Interoperability Framework, ... your current medication management solution by automating the collection and ...
Cached Medicine Technology:Sheffield Bio-Science Wins 2010 Lilly Global Supplier Award 2Holon: The Process Adaptive Interoperability Framework 2
(Date:6/17/2013)... Essential tremor (ET) is the most common ... people in the United States, and millions more worldwide. ... causes ET, there are no medications specifically designed to ... Tremor© is the International Essential Tremor Foundation’s annual research ... cure for this life-altering neurological condition. , “Although millions ...
(Date:6/17/2013)... of people who registered themselves as organ donors 21-fold ... social media might be an effective tool to address ... The gains were made in May 2012 when the ... share their organ donor status with friends and provided ... department of motor vehicle websites. The findings are being ...
(Date:6/17/2013)... June 17, 2013 Bust’DD (pronounced ‘busted’), a ... and well-fitting to women with large busts, will soon launch ... two women who understand the problem of ill-fitting bras and ... women. Their goal is to raise at least $25,000 to ... offering their bras on a wide scale. , In order ...
(Date:6/17/2013)... 2013 The producers of Impact with ... of reports highlighting how sustainable farming techniques are helping ... and their demand on food supplies. , Impact ... series airing in markets around the country on public ... Sheen, who is marking the start of his second ...
(Date:6/17/2013)... As da Vinci robot lawsuit claims ... Liebhard LLP notes that a recent report aired on ... disturbing robotic surgery complications alleged to have been caused by ... June 14th broadcast revealed that the U.S. Food & Drug ... Vinci patients who suffered burns, cuts and infections since 2007. ...
Breaking Medicine News(10 mins):Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:The Facebook effect: Social media dramatically boosts organ donor registration 2Health News:The Facebook effect: Social media dramatically boosts organ donor registration 3Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 2Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 3Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on NBC Report Detailing Robotic Surgery Complications 3
... the Children of Love Canal Are Not Counted In the ... Speak &,Ask What Have We Learned?, FALLS CHURCH, Va., ... for Health, Environment & Justice:, WHAT:, Press Conference ... Love Canal once stood., Rain or Shine, WHEN:, ...
... YORK, July 26, 2008 The following news tips are ... 2008 International Conference to be held in Chicago from July ... specific date and time. , Brain Atrophy and Biomarkers ... Susan de Santi, Ph.D., Associate Professor, Department of Psychiatry, NYU ...
... FE SPRINGS, Calif., July 29 IQAir announced ... (USOC) with ultra-high,efficiency air cleaning for USA athletes ... the optimum performance environment., (Photo: http://www.newscom.com/cgi-bin/prnh/20080729/LATU099 ... able to support the performance efforts of the,USOC ...
... SAN JOSE, Calif., July 29 VNUS(R) Medical,Technologies, Inc. (Nasdaq: ... for the full year 2008. Full-year 2008 net income is ... income of $0.77,to $0.85 per share which is changed from ... or income of $0.68 to $0.74 per,share., ABOUT VNUS ...
... AGAWAM, Mass., July 29 Microtest Laboratories has,launched ... compounding pharmacies,in the U.S. that have yet failed ... 797) regulations. Microtest also announced,its offer of a ... USP 797 compliance level and corresponding,preparation., Pharmacies ...
... Health and Charitable Care and Coverage, OAKLAND, ... it has approved more than 415 community benefit ... second quarter of 2008.,The quarter,s contributions continue to ... a measurable impact on the health of,its communities., ...
Cached Medicine News:Health News:30 Years After State of Emergency Declared at Love Canal, NY Closing the 99th Street School Triggering the Federal Superfund Program; Schools & Communities Across the Nation Still at Risk of Toxic Contamination 2Health News:New Alzheimer's predictors advance earlier detection 2Health News:New Alzheimer's predictors advance earlier detection 3Health News:New Alzheimer's predictors advance earlier detection 4Health News:New Alzheimer's predictors advance earlier detection 5Health News:New Alzheimer's predictors advance earlier detection 6Health News:New Alzheimer's predictors advance earlier detection 7Health News:New Alzheimer's predictors advance earlier detection 8Health News:IQAir to Provide U.S. Athletes With Ultra-High Efficiency Air Cleaning at the Beijing 2008 Olympic Games 2Health News:VNUS Revises Upward Full-Year 2008 Net Income Guidance 2Health News:Microtest Offers New Services, Free Facility Audit, for Compounding Pharmacies Seeking USP 797 Compliance 2Health News:Microtest Offers New Services, Free Facility Audit, for Compounding Pharmacies Seeking USP 797 Compliance 3Health News:Kaiser Permanente Approves $22 Million in Community Benefit Grants in Second Quarter of 2008 2Health News:Kaiser Permanente Approves $22 Million in Community Benefit Grants in Second Quarter of 2008 3
... The QuickVue Influenza A+B test allows ... influenza type A and type B ... wash and/or nasal aspirate specimens. The ... in the rapid differential diagnosis of ...
... Antibody Detection Assay is a single use, ... (first step) detection of IgG and IgM ... or whole blood. Rapid turnaround time, ease ... Wampole PreVue B. burgdorferi antibody detection test ...
... Conforming to U.S. and international ... Nephew's TC-100 Screw and Plating System* ... and ease of use for open ... However, the TC-100 system works well ...
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
Medicine Products: